Cargando…
Designing consensus immunogens to break tolerance to self-antigens for cancer therapy
Autores principales: | Duperret, Elizabeth K., Yan, Jian, Weiner, David B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238978/ https://www.ncbi.nlm.nih.gov/pubmed/30473745 http://dx.doi.org/10.18632/oncotarget.26275 |
Ejemplares similares
-
Safety, Tolerability, and Immunogenicity of COVID-19 Bivalent Vaccination
por: Saxena, Divyasha, et al.
Publicado: (2023) -
Simplifying checkpoint inhibitor delivery through in vivo generation of synthetic DNA-encoded monoclonal antibodies (DMAbs)
por: Perales-Puchalt, Alfredo, et al.
Publicado: (2019) -
Breaking self-tolerance in nonobese diabetic mice
Publicado: (1996) -
Epitope-optimization creates highly immunogenic alpha fetoprotein antigen to break immune tolerance and potently activates CD8 T cells to prevents autochthonous hepatocellular carcinoma
por: Hong, Yuan, et al.
Publicado: (2013) -
A minimal T-cell immunogen designed to cover HIV-1 specificities associated with control is immunogenic in mice and breaks CTL immunodominance
por: Mothe, B, et al.
Publicado: (2012)